MedPath

The effect of Timolol cream in the treatment of eczema

Phase 3
Conditions
eczema.
Atopic dermatitis, unspecified
L20.9
Registration Number
IRCT20150706023081N3
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
32
Inclusion Criteria

Patients referred to Alzahra and Sediqah Tahereh skin clinic
Presence of hand or foot eczema complication

Exclusion Criteria

Cardiac arrhythmia disorders
Hypertension
History of syncope
Pregnancy
Breastfeeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Modified Total Lesion Symptom Score( mTLSS). Timepoint: At the beginning of the study and 4 weeks and 8 weeks after the start of treatment. Method of measurement: Taking pictures and measuring the modified Total Lesion Symptom Score.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath